Loading clinical trials...
Loading clinical trials...
Gender dysphoria is defined as a persistent incongruence between an experienced gender and the assigned sex at birth Transgender and gender nonconforming persons desire to modify their appearance to be consistent with their self-identified gender identities. In non-binary people, contrary to binary transgender persons, self-identified gender identities do not fit the classical pattern male/female. During the last decennium, an increase in the number of young subjects, especially children and adolescents, referred to gender identity centres has been observed. A new nosological entity "rapid-onset gender dysphoria in adolescents and young adults" has recently been described in the literature, whose etiology has not been well understood. This growing demand of adolescents and young adults observed in the recent years is not well understood.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital of Nancy
Vandœuvre-lès-Nancy, France
Start Date
October 1, 2020
Primary Completion Date
December 1, 2020
Completion Date
January 1, 2021
Last Updated
August 13, 2020
20
ESTIMATED participants
qualitative study
OTHER
Lead Sponsor
Central Hospital, Nancy, France
NCT07252687
NCT07147166
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions